An epidemic of exclusion that must be cured

An epidemic of exclusion that must be cured

Albert Bourla, chairman and CEO of Pfizer, gave a speech on inclusion at the Asia Pacific Economic Cooperation Leaders Week in San Francisco on November 16-17.
The game-changers in pharmaceuticals

The game-changers in pharmaceuticals

Innovative pharmaceuticals are emerging as a game-changer in reshaping the industry.
Pfizer takes big steps with new vaccines

Pfizer takes big steps with new vaccines

Biopharmaceutical company Pfizer has announced that its two-in-one flu and COVID-19 jab will be moving into a final-stage trial in the coming months.
Pfizer seeks to boost presence in Vietnam

Pfizer seeks to boost presence in Vietnam

A business mission led by Anil Argilla, president of Emerging Markets Asia at Pfizer, worked with Deputy Minister of Health Do Xuan Tuyen on May 25.
Multinational pharma groups keen on robust partnerships

Multinational pharma groups keen on robust partnerships

After making gains in 2022, multinational corporations will prioritise strengthening local partnerships to support their ambition of transforming the treatment landscape – but they are also pleading for further legal clarity.
Pfizer lifts 2022 forecast for Covid-19 vaccine sales as profits rise

Pfizer lifts 2022 forecast for Covid-19 vaccine sales as profits rise

Pfizer reported higher quarterly profits Tuesday as it lifted its full-year forecast for coronavirus vaccine sales and predicted Covid-19 would yield billions more in revenues for the forseeable future.
Singapore authorises use of Pfizer’s COVID-19 vaccine on under-five children

Singapore authorises use of Pfizer’s COVID-19 vaccine on under-five children

Singapore has recently approved Pfizer's Comirnaty COVID-19 vaccine for use on children aged six months to four years.
US pharma giants commit to Vietnam

US pharma giants commit to Vietnam

As Vietnam is striving to attract more private and foreign investment in the healthcare sector, US pharma giants are continuing to reinforce moves to expand in Vietnam to tap into the growing healthcare demand in the country.
Vietnam covers bases thanks to US vaccine schemes

Vietnam covers bases thanks to US vaccine schemes

Vietnam’s battle to be rid of the coronavirus pandemic is expected to become more effective thanks to fresh commitments from the United States to help the Southeast Asian nation ensure health and safety for all.
Pfizer focused on expanding vaccine capabilities

Pfizer focused on expanding vaccine capabilities

While being accused of pandemic profiteering as profits double, US pharma giant Pfizer is running ahead with strong moves to support vulnerable populations, while seemingly attempting to hold onto the secrets of its COVID-19 vaccine recipe.
Vietnam asks Pfizer to soon provide 22 million vaccine doses

Vietnam asks Pfizer to soon provide 22 million vaccine doses

Prime Minister Pham Minh Chinh has proposed Chairman and CEO of Pfizer Albert Bourla help accelerate the delivery of 22 million doses of its COVID-19 vaccine for children aged 5-11 in Vietnam in the coming days, with a goal of completing the contract in April or May at the latest.
Pfizer Vietnam wins Top 100 Vietnam Best Places to Work in 2021

Pfizer Vietnam wins Top 100 Vietnam Best Places to Work in 2021

Pfizer Vietnam was ranked seventh amongst the Top 100 Vietnam Best Places To Work 2021 and the Top 2 Best Workplaces in the pharmaceuticals/healthcare industry.
Pharma giants beat revenue expectations

Pharma giants beat revenue expectations

Pharmaceutical companies like Pfizer, Novartis, Roche, and GSK performed well in the first three quarters of 2021, with plans to venture further into the lucrative Vietnamese market.
Pfizer, BioNTech, Moderna making $1,000 profit every second: analysis

Pfizer, BioNTech, Moderna making $1,000 profit every second: analysis

Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful Covid-19 vaccines while the world's poorest countries remain largely unvaccinated, according to a new analysis.
Pfizer strikes global licensing deal for Covid pill

Pfizer strikes global licensing deal for Covid pill

US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world's least-wealthy countries.
1 2